Chengda Pharmaceuticals Co.,Ltd.’s Net Profit Rose 6.2% in 2022

Chengda Pharmaceuticals Co.,Ltd. (诚达药业股份有限公司) (301201.SZ) reported a net profit of 106.5 million yuan in 2022, up 6.2% year-on-year.

Meanwhile, the company posted 411.5 million yuan in revenue, down 1% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 105.8 million yuan in total liabilities, with a liability-to-asset ratio of 4.6%.